FUNDACION DE ESTUDIOS NEUROLOGICOS ILUNDAIN - Spain 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2010 0 5.859.468 60.750 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ASOCIACION INSTITUTO BIODONOSTIA1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
FONDAZIONE CASA SOLLIEVO DELLA SOFFERENZA1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO DE MEDICINA MOLECULAR1
ISTANBUL UNIVERSITESI1
KATHOLIEKE UNIVERSITEIT LEUVEN1
LUNDS UNIVERSITET1
NOVARTIS PHARMA1
OSLO UNIVERSITETSSYKEHUS HF1
SEMMELWEIS EGYETEM1
STICHTING VU1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE UNIVERSITY OF SHEFFIELD1
TROPHOS1
UNITED ARAB EMIRATES UNIVERSITY1
UNIVERSITAT ZU LUBECK1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF AARHUS1
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG1

Constancy:

Total number of partners: 23
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 23
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2010-07-01Development of a strategy to treat limb-girdle muscular dystrophy (LGMD2A) using combined cell and gene therapy strategies LGMD2Aparticipant100.0002
2010-04-01European Project on Mendelian Forms of Parkinson’s Disease MEFOPAparticipant5.759.46823